Showing results 5 to 5 of 5
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Efficacy and safety analysis of Chinese patients in monarchE: abemaciclib combined with adjuvant endocrine therapy for high-risk HR+, HER2− early breast cancer Proceeding/Conference:Journal of Clinical Oncology | 2021 | 12 |